Heather Gay said she can’t “win” no matter what. In a September 2024 interview with E! News, the 50-year-old “Real Housewives ...

U.S. telehealth company Hims & Hers Health on Wednesday said it will sell compounded versions of Novo Nordisk's popular ...

Eli Lilly and Company ’s LLY stock has risen 21.1% in six months compared with an increase of 10.5% for the industry. The ...

Childhood obesity puts kids at risk for health conditions, bullying, and self-esteem issues. Are weight loss drugs the answer ...

THEBLACKLABEL’s new girl group MEOVV is reaching new career highs just two weeks after their highly-anticipated debut. Read ...

UNTOLD has made personal history as the group’s first album to spend 9 consecutive weeks on Billboard 200. Know more!

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 598.87% and ...

IT was the evening of Friday the 13th when Ruth Langsford went on Instagram to share a video of herself at home having a meal ...

Senator Sanders (I-Vt.) says CEOs of generic drugmakers are willing to sell Novo Nordisk’s (NVO) blockbuster obesity medicine ...

Americans are paying more than $900 a month for popular weight-loss drugs Ozempic and Wegovy, but drugmakers want to sell generic versions of the drugs for less than $100. That is according to ...

Ozempic, the blockbuster diabetes shot made by Novo Nordisk A/S, is “very likely” to be one of the next drugs targeted for a price cut in bargaining with the US government’s Medicare program ...

Sept 17 (Reuters) - Danish drugmaker Novo Nordisk (NOVOb.CO), opens new tab expects its diabetes drug Ozempic will "very likely" be on the U.S. government's 2027 list of price negotiations ...